ABBV Jan 2024 190.000 call
| Previous close | 7.30 |
| Open | 7.30 |
| Bid | 0.00 |
| Ask | 0.00 |
| Strike | 190.00 |
| Expiry date | 2024-01-19 |
| Day's range | 7.30 - 7.30 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Editor's pickYahoo Finance Video
Moody’s reduces outlook for pharma industry, Pfizer to provide additional COVID vaccine doses
Yahoo Finance's Anjalee Khemlani joins the Live show to discuss Moody's outlook for pharmaceutical industry as well as reports that Pfizer is looking to provide additional COVID-19 vaccine doses.
- Motley Fool
The 3 Best Dividend Aristocrat Stocks in the First Half of 2022: Are They Buys Now?
Dividend stocks aren't always known for generating sizzling gains. Here are the three best Dividend Aristocrat stocks in the first half of 2022. At its peak in early June, ExxonMobil stock was up more than 70%.
- Motley Fool
2 of the Safest Stocks to Buy in a Recession
Shares of AbbVie (NYSE: ABBV) are up by about 13% this year, which is a lot better than the benchmark S&P 500 index, which has lost 20% over the same period. With lots of high-margin revenue from top-selling drugs, there's a good chance that AbbVie stock will remain a safe haven even if the U.S. economy plunges into a deep recession. The top-selling drug for AbbVie is Humira.
